Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2017 -
EBIT 2017 -20,7 M
Net income 2017 -19,6 M
Debt 2017 -
Yield 2017 -
Sales 2018 -
EBIT 2018 -51,8 M
Net income 2018 -53,8 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0
Capi. / Sales2018 0
Capitalization 20,9 M
More Financials
Company
Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs.It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the... 
Sector
Pharmaceuticals
Calendar
06/08Shareholder meeting
More about the company
Latest news on GALENA BIOPHARMA INC
05/11 GALENA BIOPHARMA : reports 1Q loss
05/10 GALENA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
05/10 GALENA BIOPHARMA, INC. (NASDAQ : GALE) Files An 8-K Results of Operations and Fi..
05/10 GALENA BIOPHARMA, INC. : Results of Operations and Financial Condition, Financia..
05/10 Galena Biopharma Reports First Quarter 2017 Financial Results
05/02 GALENA BIOPHARMA, INC. (NASDAQ : GALE) Files An 8-K Unregistered Sales of Equity..
05/02 GALENA BIOPHARMA, INC. : Unregistered Sale of Equity Securities, Financial State..
04/13 APRIL 14 DEADLINE ALERT : Law Offices of Howard G. Smith Reminds Galena Biopharm..
04/13 GALENA BIOPHARMA INC : DEADLINE TOMORROW: Khang & Khang LLP Announces Securities..
04/12 GALENA BIOPHARMA INC : FRIDAY DEADLINE: Lundin Law PC Announces Securities Class..
More news
Sector news : Pharmaceuticals - NEC
05/26DJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Pharmaceuticals - NEC
Latest Tweets
05/25Brokerages Set Galena Biopharma Inc $GALE Target Price at $3.11  
05/19Galena Biopharma Inc $GALE Downgraded by Zacks Investment Research  
05/18Zacks Investment Research Downgrades Galena Biopharma Inc $GALE to Hold  
05/17Galena Biopharma downgraded by Zacks Investment Research to hold.  
05/12Galena Biopharma Inc $GALE Releases Earnings Results, Beats Expectations By $.. 
More tweets
Qtime:12
News from SeekingAlpha
2016 Galena Biopharma's (GALE) CEO Mark Schwartz on Q3 2016 Results - Earnings Cal..
2016 Galena Biopharma beats by $0.02
2016 Notable earnings after Wednesday?s close
2016 RXI PHARMACEUTICALS : Moving On Promising Scar Treatment
2016 Best And Worst Performing Stocks Of 2016
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus HOLD
Number of Analysts 3
Average target price 8,00 $
Spread / Average Target 1 333%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stephen F. Ghiglieri CEO, CFO & Principal Accounting Officer
Sanford J. Hillsberg Chairman
Bijan Nejadnik Chief Medical Officer & Executive Vice President
Stephen S. Galliker Independent Director
Rudolph Nisi Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GALENA BIOPHARMA INC-87.52%21
JOHNSON & JOHNSON10.69%341 901
ROCHE HOLDING LTD.14.62%236 581
NOVARTIS AG6.07%211 457
PFIZER INC.-1.05%191 398
MERCK & CO., INC.10.28%177 567
More Results